Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.
about
Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitusEvaluating the benefits of home-based management of atrial fibrillation: current perspectivesCost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulinA role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control studyDiabetes mellitus, glycemic control, and risk of atrial fibrillation.Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study.Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study.The impact of age on the epidemiology of atrial fibrillation hospitalizations.Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Status of the epidemiology of atrial fibrillation.Atrial conduction delay and its association with left atrial dimension, left atrial pressure and left ventricular diastolic dysfunction in patients at risk of atrial fibrillation.The cardiometabolic syndrome and cardiovascular disease.The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmiasDiabetes mellitus is an independent risk factor for atrial fibrillation in a general Chinese populationStroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Impact of Metabolic Syndrome on Ablation-Outcome in Patients with Atrial Fibrillation: A Systematic Review.Clinical pharmacokinetics and pharmacodynamics of vildagliptin.Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies.Management and prognosis of atrial fibrillation in the diabetic patient.Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus.Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy.Diabetes and new-onset atrial fibrillation in a hypertensive population.Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study.Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm SocieCathepsin A mediates susceptibility to atrial tachyarrhythmia and impairment of atrial emptying function in Zucker diabetic fatty rats.Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR).European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Societ
P2860
Q27014826-C1E9681F-92A3-4AD0-BF70-82DB50C46DF7Q28079137-C73A29EA-9689-4D03-BF40-27C2D4CB0F21Q28268410-D1F05EC0-82D0-437C-9F85-224AB63FD745Q33240337-5FBDF54C-2AF2-4AF9-9EC9-5A18ABEEBC81Q33959715-E4D1141E-5259-482E-A4C7-F7A6A833C7C0Q34452521-9DD46ADC-FEF7-4C30-91AB-43D844B5E412Q34774249-021614BB-5B01-4331-9D95-DDF88BEA8AF7Q34985247-169C0A64-11D7-43AB-9644-87B925701777Q35236071-7FB78354-EE20-46B5-BEE7-AC062A746B87Q35610699-F4B37105-69BD-49F5-8959-375769250D75Q35620065-F0110482-98C2-4A82-BBE3-050CE7561D90Q36382360-121F7F9E-678F-4E62-B389-2FDF8CA7719FQ36464561-26932840-AD10-4979-805A-2CFCDE6414A3Q36608447-57DEA0D1-6A29-4FE6-896C-74A21BA68533Q36901530-43945A8C-C6B6-4F83-857B-9CFC3A7EB6E8Q37011175-51E8D4DB-D834-45BD-91C4-AAFCFAA0E639Q37227435-F49D8B6E-09C2-42B2-ABB2-1A6E6C81B4C7Q37495877-7CC69EE5-CB9A-45C5-86FE-25B228E7FDDAQ37495968-60E065C8-FBE0-4240-BE54-1058338EEB6DQ37984567-F1204CBB-52CD-45D5-9F3C-F96A612078B7Q38234313-867BA474-76DF-4A0A-8D9F-E5826BA684A5Q38497702-387C94CA-D9BA-48FB-A780-06558769E257Q39409421-C2A09397-7C11-45CA-AEB5-BCD4369B6FBFQ39635843-F408B069-967F-4934-810E-AAF185F174BBQ40873653-58B97591-6668-48C5-BF39-2C32B4EB51D6Q41502885-FD59DAED-D8F7-4F71-A821-E887AD573F98Q46090464-829009A7-5EA3-4D4A-ADA9-A4A9B7DA47ABQ46734928-7D570B5F-EB6C-4D83-88D4-DE9CA8EAAD63Q47297790-036A76B0-B3B2-4C67-99D0-F8F0687E7B61Q47796802-EE56EBFF-4F08-4724-83CF-3A1FA50ED297Q53133810-71D6FE0F-1215-4EC8-88EF-47114A6D5949Q53211716-073EB1D6-1C0E-48AA-B5EF-F1697B619988Q57072097-B49ECE27-B738-498D-9F64-1CCDC8690448
P2860
Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Atrial fibrillation and its as ...... ension in a Swedish community.
@en
Atrial fibrillation and its as ...... ension in a Swedish community.
@nl
type
label
Atrial fibrillation and its as ...... ension in a Swedish community.
@en
Atrial fibrillation and its as ...... ension in a Swedish community.
@nl
prefLabel
Atrial fibrillation and its as ...... ension in a Swedish community.
@en
Atrial fibrillation and its as ...... ension in a Swedish community.
@nl
P2093
P2860
P921
P1476
Atrial fibrillation and its as ...... ension in a Swedish community.
@en
P2093
P2860
P304
P356
10.1111/J.1462-8902.2004.00358.X
P50
P577
2004-09-01T00:00:00Z